A Study to Describe the Persistence With Ozanimod Treatment in Relapsing-Remitting Multiple Sclerosis (RRMS) Participants
Clinical trial NCT05811416 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05811416
- Sponsor
- Bristol-Myers Squibb
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-06-14
- Primary completion
- 2027-01-20
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.